The Conglomerate Carve-Out Wave Is Restructuring the Mass-to-Premium Shelf

Three concurrent portfolio restructurings are actively reshaping who controls the drugstore and mid-market beauty shelf in 2026. Coty's strategic review of CoverGirl, Rimmel, Max Factor, and Sally Hansen — a ~$1.2B revenue mass color business — is ongoing with Citi as financial adviser, with WSJ reporting the review re-emerging as recently as May 26, 2026. Henkel agreed to acquire Olaplex in a $1.4B deal announced March 25 at a 55% premium to the prior day's closing price, with closure targeted for H2 2026. And Kimberly-Clark's agreed acquisition of Kenvue in a $48.7B deal — which puts Neutrogena, Aveeno, OGX, and Clean & Clear into an entity primarily known for Kleenex and Huggies — is expected to close H2 2026.

These three moves in parallel represent a structural re-sorting of the mass-to-premium bridge. Coty's CoverGirl, once the largest cosmetics brand in mass U.S. retail, could be acquired by a financial buyer or mid-tier strategic with no natural clean beauty distribution. That matters because CoverGirl had been actively repositioning under "Clean Fresh" — a clean-adjacent platform — and its fate under a distressed sale could undo that repositioning entirely, or alternatively, land it with a buyer who accelerates the clean transition.

The Olaplex/Henkel deal is more cleanly legible: a bond-builder brand with a science narrative goes into Schwarzkopf's house, where professional channel synergies are obvious. The Kenvue/Kimberly-Clark outcome is the murkiest for clean beauty — Neutrogena's derm-to-consumer positioning and Aveeno's oat-based naturals thesis sit oddly alongside tissue paper. None of these acquirers are clean-native; all three transactions will be tested on whether they preserve or dilute the clean-adjacent positioning each asset has been building.